Skip to main content

Table 1 HA levels in patients serum samples

From: Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

Tissue n Patient age (years)
Median (range)
HA serum level (μg/ml)
Median (range)
Normal ovaries 27 50 (48–58) 9.6 (0.6–114.3)
Benign ovarian tumors 22 51 (35–62) 17.3 (1–136.5)
Ovarian cancers Total 101 61 (25–90) 28.7 (0.3–1543.7)
Serous 59 61 (25–85) 26.7 (0.3–172.8)
Endometrioid 16 55 (33–90) 37.0 (4.2–1543.9)
Mucinous 7 54 (37–74) 26.2 (1.5–70.7)
Clear Cell 9 62 (37–82) 25.9 (2.2–101.9)
Others 10 60 (32–88) 25.5 (13.6–111.9)
Stage    
1 31 55 (33–90) 26.0 (1.1–1543.7)
2 6 59 (44–65) 19.0 (1.5–37.0)
3 58 62 (25–88) 29.6 (0.3–172.8)
  4 4 64 (61–79) 19.8 (15.8–89.3)